venerdì, 27 novembre 2020
Medinews
12 Ottobre 2018

Human medicine European public assessment report (EPAR): Trastuzumab Amgen Europe B.V.

October 8, 2018 – This Human medicine European public assessment report (EPAR) was updated.
Leggi tutto

TORNA INDIETRO